Suppr超能文献

静脉-静脉体外膜肺氧合可改善创伤后呼吸衰竭患者的预后。

VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION IMPROVES OUTCOMES IN TRAUMA PATIENTS SUFFERING RESPIRATORY FAILURE.

作者信息

Powell Elizabeth K, Betzold Richard, Lammers Daniel T, Podell Jamie, Wan Ryan, Teeter William, Hardin Ronald D, Scalea Thomas M, Galvagno Samuel M

机构信息

University of Arkansas for Medical Sciences, Little Rock, Arkansas.

United States Army.

出版信息

Shock. 2025 Feb 1;63(2):248-254. doi: 10.1097/SHK.0000000000002491. Epub 2024 Oct 24.

Abstract

Introduction: Veno-venous extracorporeal membrane oxygenation (VV ECMO) improves hypoxemia and carbon dioxide clearance in patients with severe respiratory derangements. A greater understanding of the potential benefits of VV ECMO in trauma patients could lead to broader adoption. We hypothesize that trauma patients who receive VV ECMO have improved mortality outcomes when compared to those receiving conventional ventilator management given the rapid stabilization VV ECMO promotes. Methods: We performed a single-center, propensity score-matched cohort study. All trauma patients from January 1, 2014, to October 30, 2023, who were placed on VV ECMO or who would have met institutional guidelines for VV ECMO but were managed with conventional ventilator strategies were matched 1:1. The primary outcome analysis was survival at hospital discharge. Significance was defined as P < 0.05. Results: Eighty-one trauma VV ECMO patients and 128 patients who received conventional management met criteria for inclusion. After matching, VV ECMO and conventional treatment cohort characteristics were similar in age and mechanism of injury. Matched ISS, SI, lactate levels, and frequency of traumatically brain injured were also similar. Finally, respiratory parameters including preintervention, pH, partial pressure of carbon dioxide, lactate levels, and oxygen saturation were similar between matched groups. VV ECMO patients had higher survival rates at discharge when compared to the matched conventional treatment group (70% vs. 41%, P < 0.001). Corresponding hazard ratio for VV ECMO use was 0.31 (95% CI 0.18-0.52; P < 0.001). The odds ratio of mortality in matched trauma patients who receive VV ECMO versus conventional treatment was 0.29 (95% CI 0.14-0.58; P < 0.001). Conclusion: VV ECMO may represent a safe, alternative treatment approach for appropriately screened trauma patients with acute respiratory failure; however, further studies are warranted.

摘要

引言

静脉-静脉体外膜肺氧合(VV ECMO)可改善严重呼吸紊乱患者的低氧血症和二氧化碳清除。更深入了解VV ECMO对创伤患者的潜在益处可能会使其得到更广泛的应用。我们假设,鉴于VV ECMO能促进快速稳定,与接受传统呼吸机管理的创伤患者相比,接受VV ECMO的创伤患者死亡率更低。方法:我们进行了一项单中心、倾向评分匹配队列研究。将2014年1月1日至2023年10月30日期间所有接受VV ECMO治疗或符合本机构VV ECMO标准但采用传统呼吸机策略管理的创伤患者进行1:1匹配。主要结局分析是出院时的生存率。显著性定义为P < 0.05。结果:81例接受VV ECMO治疗的创伤患者和128例接受传统治疗的患者符合纳入标准。匹配后,VV ECMO组和传统治疗组在年龄和损伤机制方面的特征相似。匹配后的损伤严重度评分(ISS)、简明损伤定级(AIS)、乳酸水平和创伤性脑损伤频率也相似。最后,匹配组之间的呼吸参数,包括干预前的pH值、二氧化碳分压、乳酸水平和氧饱和度也相似。与匹配的传统治疗组相比,VV ECMO患者出院时的生存率更高(70%对41%,P < 0.001)。使用VV ECMO的相应风险比为0.31(95%可信区间0.18 - 0.52;P < 0.001)。接受VV ECMO治疗的匹配创伤患者与传统治疗患者的死亡比值比为0.29(95%可信区间0.14 - 0.58;P < 0.001)。结论:对于经过适当筛选的急性呼吸衰竭创伤患者,VV ECMO可能是一种安全的替代治疗方法;然而,仍需进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验